Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-02-08 @ 1:05 AM
Study NCT ID:
NCT01009593
Status:
TERMINATED
Last Update Posted:
2012-09-10
First Post:
2009-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Sponsor:
Abbott
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatocellular Carcinoma Non-resectable | View |
| None | Hepatocellular Carcinoma Recurrent | View |
| None | Carcinoma, Hepatocellular | View |
| None | Liver Diseases | View |
| None | Neoplasms by Histologic Type | View |
| None | Digestive System Neoplasms | View |
| None | Carcinoma | View |
| None | Liver Neoplasms | View |
| None | Neoplasms | View |
| None | Neoplasms by Site | View |
| None | Digestive System Diseases | View |
| None | Adenocarcinoma | View |
| None | Neoplasms, Glandular and Epithelial | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Antineoplastic Agents | View |
| None | Growth Substances | View |
| None | Physiological Effects of Drugs | View |
| None | Enzyme Inhibitors | View |
| None | Angiogenesis Inhibitors | View |
| None | Inhibitors, Angiogenesis | View |
| None | Protein Kinase Inhibitors | View |
| None | Pharmacologic Actions | View |
| None | Growth Inhibitors | View |
| None | Angiogenesis Modulating Agents | View |
| None | Sorafenib | View |